Updates are available Correction dated 2024-10-15
Click to view Correction: https://doi.org/10.1038/s41596-024-01087-8
-
Authors
Fitzgerald, Michael Q.
Chu, Tiffany https://orcid.org/0009-0000-2318-3960
Puppo, Francesca
Blanch, Rebeca https://orcid.org/0000-0001-6726-4084
Chillón, Miguel https://orcid.org/0000-0003-0840-2111
Subramaniam, Shankar
Muotri, Alysson R. https://orcid.org/0000-0003-0867-2875
- License Information
-
More Information
Article History
Received: 22 June 2023
Accepted: 22 February 2024
First Online: 3 May 2024
Change Date: 15 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41596-024-01087-8
Competing interests
: A.R.M. is a cofounder of and has an equity interest in TISMOO, a company dedicated to genetic analysis and brain organoid modeling focusing on therapeutic applications customized for autism spectrum disorder and other neurological disorders with genetic origins. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies. A.R.M. is an inventor of several patents related to human functional brain organogenesis, including the protocol described here.
